Welcome to EQUITY DEVELOPMENT

The UK's longest established regulated provider of sponsored equity research.

We launched EQUITY DEVELOPMENT in 1997 becoming the first ever  regulated provider of Sponsored Equity Research in the UK.

Our research teams are made up of expert analysts with deep understanding & experience in their sectors.  Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).

We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.

 

FREE REGISTRATION

Sign up today and access the very latest company research

LOG IN

For access to all company research please

Lombard Medical Technologies Plc

Lombard Medical Technologies PLC (LMT) discovers, develops, assembles and markets innovative cardiovascular devices with a particular focus in the areas of stent-graft, stapling systems and polymer coatings for implantable medical devices.

Clinical Procedures recommenced; Good news

  • Refix™ Endostapler now CE marked
  • Distribution and licensing deal with Medtronic worth up to US$8m
  • Design of US Aorfix trial changed and speeded up
  • Fair value of 47p vs current 34p, with significant newsflow expected

Publication Date:
January 30 2007

Lombard Medical; well placed to grow

  • Unique product in a growing market, endorsed by medical community
  • Strong pipeline of products
  • Profitability expected in 2009
  • Fair value/share 89p vs current 77p

Publication Date:
October 2 2006

previous